Suppr超能文献

尼古丁替代疗法:对尼古丁受体途径机制及潜力的见解

Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.

作者信息

Patidar Nishant, Navale Archana M, Parsaila Nitesh, Sharma Dinesh, Nahar Prachi, Shinde Sagar, Solanki Nilay, Shelke Ajay

机构信息

Department of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.

Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology Changa, Gujarat, India.

出版信息

Am J Transl Res. 2025 Apr 15;17(4):2396-2410. doi: 10.62347/MOBZ7773. eCollection 2025.

Abstract

Nicotine addiction is a complex phenomenon entwined with intricate mechanisms within the nicotine receptor pathway. This review offers an insightful exploration of this multifaceted landscape, delving into the interplay between nicotinic acetylcholine receptors (nAChRs) and their pivotal role in neurotransmission. The structural and functional aspects of nAChRs, their distribution within the peripheral and central nervous systems, and their involvement in modulating diverse signalling cascades are reviewed. The clinical implications of nicotine addiction and the challenges in smoking cessation are also explored. Nicotine Replacement Therapy (NRT) drugs, designed to alleviate withdrawal symptoms and aid in smoking cessation, are critically evaluated. This article synthesizes current research findings on the efficacy, safety, and limitations of various NRT modalities. Furthermore, emerging pharmacotherapeutic strategies and novel molecules aimed at optimizing NRT outcomes are discussed. The potential of leveraging a deeper understanding of the nicotine receptor pathway to develop more targeted and efficacious NRT interventions is emphasized. The exploration of adjunct therapies and combination approaches to enhance the success rates of smoking cessation is also addressed. Through a synthesis of preclinical and clinical evidence, this article aims to provide a comprehensive resource for researchers, clinicians, and policymakers working towards advancing the field of nicotine addiction treatment. As the global effort to combat tobacco-related health challenges intensifies, a nuanced understanding of the nicotine receptor pathway and its therapeutic implications becomes increasingly imperative.

摘要

尼古丁成瘾是一种复杂的现象,与尼古丁受体途径中的复杂机制相互交织。本综述对这一多面领域进行了深入探讨,深入研究了烟碱型乙酰胆碱受体(nAChRs)之间的相互作用及其在神经传递中的关键作用。综述了nAChRs的结构和功能方面、它们在周围和中枢神经系统中的分布,以及它们参与调节多种信号级联反应的情况。还探讨了尼古丁成瘾的临床意义以及戒烟面临的挑战。对旨在减轻戒断症状和帮助戒烟的尼古丁替代疗法(NRT)药物进行了严格评估。本文综合了当前关于各种NRT方式的疗效、安全性和局限性的研究结果。此外,还讨论了旨在优化NRT效果的新兴药物治疗策略和新型分子。强调了利用对尼古丁受体途径的更深入理解来开发更具针对性和有效性的NRT干预措施的潜力。还探讨了辅助疗法和联合方法以提高戒烟成功率。通过综合临床前和临床证据,本文旨在为致力于推进尼古丁成瘾治疗领域的研究人员、临床医生和政策制定者提供全面的资源。随着全球应对烟草相关健康挑战的努力不断加强,对尼古丁受体途径及其治疗意义的细致理解变得越来越迫切。

相似文献

1
Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.
Am J Transl Res. 2025 Apr 15;17(4):2396-2410. doi: 10.62347/MOBZ7773. eCollection 2025.
2
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Neuropharmacology. 2020 Nov 1;178:108225. doi: 10.1016/j.neuropharm.2020.108225. Epub 2020 Aug 3.
3
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2.
4
Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6.
5
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Psychopharmacology (Berl). 2018 Sep;235(9):2479-2505. doi: 10.1007/s00213-018-4921-9. Epub 2018 Jul 7.
6
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
7
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
8
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
9
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
10
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.

本文引用的文献

1
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines' immunogenicity.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2140552. doi: 10.1080/21645515.2022.2140552. Epub 2022 Nov 9.
3
Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation.
Psychopharmacology (Berl). 2021 Nov;238(11):3335-3346. doi: 10.1007/s00213-021-05949-x. Epub 2021 Oct 14.
5
Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.
Neuropharmacology. 2020 May 15;168:108008. doi: 10.1016/j.neuropharm.2020.108008. Epub 2020 Feb 12.
7
Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.
J Am Coll Cardiol. 2018 Aug 28;72(9):1030-1045. doi: 10.1016/j.jacc.2018.06.036.
9
Effects of concurrent blockade of OX2 and CB1 receptors in the ventral tegmental area on nicotine-induced place preference in rats.
Neurosci Lett. 2018 Sep 25;684:121-126. doi: 10.1016/j.neulet.2018.07.017. Epub 2018 Jul 12.
10
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Psychopharmacology (Berl). 2018 Sep;235(9):2479-2505. doi: 10.1007/s00213-018-4921-9. Epub 2018 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验